Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$694,653
-$5,276,663 QoQ
Shares Held
14,481
-91.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $29,070,840 across 29 Biotechnology names. RPRX ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
250,000 | $10,057,500 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
236,000 | $5,059,840 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
265,730 | $3,842,455 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,895 | $1,739,273 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
29,061 | $813,998 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
14,481 | $694,653 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
22,735 | $506,081 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
112,170 | $481,209 |
All Filings in RPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $694,653 | 14,481 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $5,971,316 | 169,255 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $677,364 | 18,800 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $541,831 | 17,841 | Shares | Sole | 2024-05-01 | |
| 2023-09-30 | $208,978 | 7,700 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||